(Q36373068)

13 August 2017

1 reference

title

Antisense inhibitors of HIV: problems and perspectives (English)

1 reference

13 August 2017

Antisense inhibitors of HIV: Problems and perspectives (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

20 October 2022

G. Degols

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642480

20 October 2022

J. P. Leonetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642480

20 October 2022

P. Milhaud

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642480

20 October 2022

N. Mechti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642480

20 October 2022

B. Lebleu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642480

20 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1642480

20 October 2022

publication date

1 April 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:016635429290023X?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

https://api.elsevier.com/content/article/PII:016635429290023X?httpAccept=text/plain

20 October 2022

1 reference

Crossref

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

20 October 2022

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

279-287

1 reference

Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Sequence-specific recognition and cleavage of duplex DNA via triple-helix formation by oligonucleotides covalently linked to a phenanthroline-copper chelate

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Oligodeoxynucleotides covalently linked to intercalating agents: a new class of gene regulatory substances

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Reactive oligonucleotide derivatives and sequence-specific modification of nucleic acids

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Intracellular distribution of microinjected antisense oligonucleotides

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Sequence-selective DNA recognition by synthetic ligands

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Ribozymes as potential anti-HIV-1 therapeutic agents.

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity.

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Regulation of HIV gene expression by RNA-protein interactions

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Thermostability of double-stranded deoxyribonucleic acids: effects of covalent additions of a psoralen

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Sequence-specific DNA binding by the c-Myc protein

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Inhibition in vitro transcription by specific double-stranded oligodeoxyribonucleotides

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0166-3542(92)90023-X

20 October 2022

Identifiers

1 reference

13 August 2017

1 reference